Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity
Molecular Oncology · 2025
DOI: 10.1002/1878-0261.70144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Liqun He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics and Pathology, Uppsala University, Sweden. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Breast Neoplasms, Capillary Permeability, Triple Negative Breast Neoplasms. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Exodiab, Trond Mohn Stiftelse, Cancerfonden.
Abstract (Originalsprache)
The vasculature and the immune system both play roles in breast cancer progression and metastasis. In an experimental mouse model of Shb ‐gene deficiency in endothelial cells, breast cancer lung metastasis correlated with immune suppression rather than with vascular leakage. The present study aimed to assess underlying gene expression changes in endothelial and immune cells responsible for this phenotype and to explore their relationship to human disease. Mouse endothelial cell Shb ‐gene deficiency, leading to ‘vessel normalization’, resulted in altered expression of chemo/cytokine genes and upregulation of immune checkpoint genes in immune cells. Endothelial cells under these conditions exhibited gene expression patterns compatible with reduced angiogenesis and vascular leakage. Additionally, genes whose products relate to immune cell vascular transmigration and function were affected. In a human triple‐negative breast cancer cohort, tumors with reduced vascular leakage exhibited a higher relative proportion of regulatory T cells and larger tumor size. However, these changes were not associated with increased metastasis. In conclusion, a low leakage vascular phenotype reduces tumor cell intravasation/metastasis and modifies the immune response, which in the current context becomes pro‐tumoral.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
- Department of Medical Cell Biology, Uppsala University, Sweden.
- Department of Clinical Medicine, University of Bergen, Norway.
ORCID-Profile: Michael Welsh
Förderung
- Exodiab
- Trond Mohn Stiftelse
- Cancerfonden
- Vetenskapsrådet
- Knut och Alice Wallenbergs Stiftelse
Zitieren
APA
He, L., Testini, C., Hekmati, N., Bonello, A., Schiza, A., Nwadozi, E., Phillipson, M., Strell, C., & Welsh, M. (2025). Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity. Molecular Oncology. https://doi.org/10.1002/1878-0261.70144
Vancouver
He L, Testini C, Hekmati N, Bonello A, Schiza A, Nwadozi E, et al. Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity. Molecular Oncology. 2025. doi:10.1002/1878-0261.70144
BibTeX
@article{He2025,
author = {He, Liqun and Testini, Chiara and Hekmati, Neda and Bonello, Altea and Schiza, Aglaia and Nwadozi, Emmanuel and Phillipson, Mia and Strell, Carina and Welsh, Michael},
title = {Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity},
journal = {Molecular Oncology},
year = {2025},
doi = {10.1002/1878-0261.70144}
}
EUVIMED